Cefalexin Virbac, 375 mg/8g intramammaarsuspensioon kinnislehmadele
Cefalexin Virbac, 375 mg/8g intramammaarsuspensioon kinnislehmadele
Authorised
- Cefapirin benzathine
Product identification
Medicine name:
Cefalexin Virbac, 375 mg/8g intramammaarsuspensioon kinnislehmadele
Active substance:
- Cefapirin benzathine
Target species:
-
Cattle (dairy cow at drying-off)
Route of administration:
-
Intramammary use
Product details
Active substance and strength:
-
Cefapirin benzathine504.70/milligram(s)1.00Syringe
Pharmaceutical form:
-
Intramammary suspension
Withdrawal period by route of administration:
-
Intramammary use
-
Cattle (dairy cow at drying-off)
-
Meat and offal4day
-
Milk12hourPiimale: 12 tundi peale poegimist, kui kinnisperiood on 42 päeva või pikem; 42,5 päeva pärast manustamist, kui kinnisperiood on lühem kui 42 päeva.
-
-
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QJ51DB01
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
Estonia
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Full application (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
- Virbac
Marketing authorisation date:
Manufacturing sites for batch release:
- Virbac
Responsible authority:
- State Agency Of Medicines
Authorisation number:
- 1214
Date of authorisation status change:
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Summary of Product Characteristics
English (PDF)
Download Published on: 3/03/2022
Estonian (PDF)
Published on: 3/03/2022
Labelling
This document does not exist in this language (English). You can find it
in another language below.
Estonian (PDF)
Published on: 4/05/2022
